Trial intelligence / Profile preview

Intravenous terlipressin in hepatorenal syndrome type 1 (phase III, double-blind, placebo-controlled)

2004-005182-37Phase 3Completed

Sponsor
Curatis
Start
Aug 2006
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of terlipressin in hepatorenal syndrome type 1 (HRS-1), hepatorenal syndrome (HRS), sponsored by Curatis. Started Aug 2006; status: completed.

02

Drugs

terlipressin
03

Conditions

hepatorenal syndrome type 1 (HRS-1)hepatorenal syndrome (HRS)

Beyond the preview

Go deeper on 2004-005182-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005182-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call